Report Cover

Global and United States Psoriasis Drug Market Insights, Forecast to 2026


Psoriasis Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Psoriasis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Psoriasis Drug market is segmented into
    External Use
    Oral
    Injection

Segment by Application, the Psoriasis Drug market is segmented into
    Hospital
    Drugs Store

Regional and Country-level Analysis
The Psoriasis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Psoriasis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Psoriasis Drug Market Share Analysis
Psoriasis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Psoriasis Drug business, the date to enter into the Psoriasis Drug market, Psoriasis Drug product introduction, recent developments, etc.
The major vendors covered:
    AbbVie
    Johnson & Johnson
    Bayer
    Galderma
    Bristol-Myers Squibb
    Novartis
    Pfizer
    Merz Pharma
    Valeant
    LEO Pharma
    GlaxoSmithKline
1 Study Coverage
    1.1 Psoriasis Drug Product Introduction
    1.2 Market Segments
    1.3 Key Psoriasis Drug Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Psoriasis Drug Market Size Growth Rate by Type
        1.4.2 External Use
        1.4.3 Oral
        1.4.4 Injection
    1.5 Market by Application
        1.5.1 Global Psoriasis Drug Market Size Growth Rate by Application
        1.5.2 Hospital
        1.5.3 Drugs Store
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Psoriasis Drug Market Size, Estimates and Forecasts
        2.1.1 Global Psoriasis Drug Revenue 2015-2026
        2.1.2 Global Psoriasis Drug Sales 2015-2026
    2.2 Global Psoriasis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Psoriasis Drug Historical Market Size by Region (2015-2020)
        2.3.1 Global Psoriasis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global Psoriasis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 Psoriasis Drug Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global Psoriasis Drug Sales Forecast by Region (2021-2026)
        2.4.2 Global Psoriasis Drug Revenue Forecast by Region (2021-2026)

3 Global Psoriasis Drug Competitor Landscape by Players
    3.1 Global Top Psoriasis Drug Sales by Manufacturers
        3.1.1 Global Psoriasis Drug Sales by Manufacturers (2015-2020)
        3.1.2 Global Psoriasis Drug Sales Market Share by Manufacturers (2015-2020)
    3.2 Global Psoriasis Drug Manufacturers by Revenue
        3.2.1 Global Psoriasis Drug Revenue by Manufacturers (2015-2020)
        3.2.2 Global Psoriasis Drug Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Psoriasis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Psoriasis Drug Revenue in 2019
        3.2.5 Global Psoriasis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Psoriasis Drug Price by Manufacturers
    3.4 Global Psoriasis Drug Manufacturing Base Distribution, Product Types
        3.4.1 Psoriasis Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Psoriasis Drug Product Type
        3.4.3 Date of International Manufacturers Enter into Psoriasis Drug Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Psoriasis Drug Market Size by Type (2015-2020)
        4.1.1 Global Psoriasis Drug Sales by Type (2015-2020)
        4.1.2 Global Psoriasis Drug Revenue by Type (2015-2020)
        4.1.3 Psoriasis Drug Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Psoriasis Drug Market Size Forecast by Type (2021-2026)
        4.2.1 Global Psoriasis Drug Sales Forecast by Type (2021-2026)
        4.2.2 Global Psoriasis Drug Revenue Forecast by Type (2021-2026)
        4.2.3 Psoriasis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Psoriasis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Psoriasis Drug Market Size by Application (2015-2020)
        5.1.1 Global Psoriasis Drug Sales by Application (2015-2020)
        5.1.2 Global Psoriasis Drug Revenue by Application (2015-2020)
        5.1.3 Psoriasis Drug Price by Application (2015-2020)
    5.2 Psoriasis Drug Market Size Forecast by Application (2021-2026)
        5.2.1 Global Psoriasis Drug Sales Forecast by Application (2021-2026)
        5.2.2 Global Psoriasis Drug Revenue Forecast by Application (2021-2026)
        5.2.3 Global Psoriasis Drug Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
    6.1 United States Psoriasis Drug Market Size YoY Growth 2015-2026
        6.1.1 United States Psoriasis Drug Sales YoY Growth 2015-2026
        6.1.2 United States Psoriasis Drug Revenue YoY Growth 2015-2026
        6.1.3 United States Psoriasis Drug Market Share in Global Market 2015-2026
    6.2 United States Psoriasis Drug Market Size by Players (International and Local Players)
        6.2.1 United States Top Psoriasis Drug Players by Sales (2015-2020)
        6.2.2 United States Top Psoriasis Drug Players by Revenue (2015-2020)
    6.3 United States Psoriasis Drug Historic Market Review by Type (2015-2020)
        6.3.1 United States Psoriasis Drug Sales Market Share by Type (2015-2020)
        6.3.2 United States Psoriasis Drug Revenue Market Share by Type (2015-2020)
        6.3.3 United States Psoriasis Drug Price by Type (2015-2020)
    6.4 United States Psoriasis Drug Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 United States Psoriasis Drug Sales Forecast by Type (2021-2026)
        6.4.2 United States Psoriasis Drug Revenue Forecast by Type (2021-2026)
        6.4.3 United States Psoriasis Drug Price Forecast by Type (2021-2026)
    6.5 United States Psoriasis Drug Historic Market Review by Application (2015-2020)
        6.5.1 United States Psoriasis Drug Sales Market Share by Application (2015-2020)
        6.5.2 United States Psoriasis Drug Revenue Market Share by Application (2015-2020)
        6.5.3 United States Psoriasis Drug Price by Application (2015-2020)
    6.6 United States Psoriasis Drug Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 United States Psoriasis Drug Sales Forecast by Application (2021-2026)
        6.6.2 United States Psoriasis Drug Revenue Forecast by Application (2021-2026)
        6.6.3 United States Psoriasis Drug Price Forecast by Application (2021-2026)

7 North America
    7.1 North America Psoriasis Drug Market Size YoY Growth 2015-2026
    7.2 North America Psoriasis Drug Market Facts & Figures by Country
        7.2.1 North America Psoriasis Drug Sales by Country (2015-2020)
        7.2.2 North America Psoriasis Drug Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe Psoriasis Drug Market Size YoY Growth 2015-2026
    8.2 Europe Psoriasis Drug Market Facts & Figures by Country
        8.2.1 Europe Psoriasis Drug Sales by Country
        8.2.2 Europe Psoriasis Drug Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific Psoriasis Drug Market Size YoY Growth 2015-2026
    9.2 Asia Pacific Psoriasis Drug Market Facts & Figures by Country
        9.2.1 Asia Pacific Psoriasis Drug Sales by Region (2015-2020)
        9.2.2 Asia Pacific Psoriasis Drug Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America Psoriasis Drug Market Size YoY Growth 2015-2026
    10.2 Latin America Psoriasis Drug Market Facts & Figures by Country
        10.2.1 Latin America Psoriasis Drug Sales by Country
        10.2.2 Latin America Psoriasis Drug Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Psoriasis Drug Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa Psoriasis Drug Market Facts & Figures by Country
        11.2.1 Middle East and Africa Psoriasis Drug Sales by Country
        11.2.2 Middle East and Africa Psoriasis Drug Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 AbbVie
        12.1.1 AbbVie Corporation Information
        12.1.2 AbbVie Description and Business Overview
        12.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 AbbVie Psoriasis Drug Products Offered
        12.1.5 AbbVie Recent Development
    12.2 Johnson & Johnson
        12.2.1 Johnson & Johnson Corporation Information
        12.2.2 Johnson & Johnson Description and Business Overview
        12.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 Johnson & Johnson Psoriasis Drug Products Offered
        12.2.5 Johnson & Johnson Recent Development
    12.3 Bayer
        12.3.1 Bayer Corporation Information
        12.3.2 Bayer Description and Business Overview
        12.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 Bayer Psoriasis Drug Products Offered
        12.3.5 Bayer Recent Development
    12.4 Galderma
        12.4.1 Galderma Corporation Information
        12.4.2 Galderma Description and Business Overview
        12.4.3 Galderma Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Galderma Psoriasis Drug Products Offered
        12.4.5 Galderma Recent Development
    12.5 Bristol-Myers Squibb
        12.5.1 Bristol-Myers Squibb Corporation Information
        12.5.2 Bristol-Myers Squibb Description and Business Overview
        12.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Bristol-Myers Squibb Psoriasis Drug Products Offered
        12.5.5 Bristol-Myers Squibb Recent Development
    12.6 Novartis
        12.6.1 Novartis Corporation Information
        12.6.2 Novartis Description and Business Overview
        12.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
        12.6.4 Novartis Psoriasis Drug Products Offered
        12.6.5 Novartis Recent Development
    12.7 Pfizer
        12.7.1 Pfizer Corporation Information
        12.7.2 Pfizer Description and Business Overview
        12.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
        12.7.4 Pfizer Psoriasis Drug Products Offered
        12.7.5 Pfizer Recent Development
    12.8 Merz Pharma
        12.8.1 Merz Pharma Corporation Information
        12.8.2 Merz Pharma Description and Business Overview
        12.8.3 Merz Pharma Sales, Revenue and Gross Margin (2015-2020)
        12.8.4 Merz Pharma Psoriasis Drug Products Offered
        12.8.5 Merz Pharma Recent Development
    12.9 Valeant
        12.9.1 Valeant Corporation Information
        12.9.2 Valeant Description and Business Overview
        12.9.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
        12.9.4 Valeant Psoriasis Drug Products Offered
        12.9.5 Valeant Recent Development
    12.10 LEO Pharma
        12.10.1 LEO Pharma Corporation Information
        12.10.2 LEO Pharma Description and Business Overview
        12.10.3 LEO Pharma Sales, Revenue and Gross Margin (2015-2020)
        12.10.4 LEO Pharma Psoriasis Drug Products Offered
        12.10.5 LEO Pharma Recent Development
    12.11 AbbVie
        12.11.1 AbbVie Corporation Information
        12.11.2 AbbVie Description and Business Overview
        12.11.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 AbbVie Psoriasis Drug Products Offered
        12.11.5 AbbVie Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Psoriasis Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Psoriasis Drug Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Psoriasis Drug Market Segments Table 2. Ranking of Global Top Psoriasis Drug Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Psoriasis Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of External Use Table 5. Major Manufacturers of Oral Table 6. Major Manufacturers of Injection Table 7. Global Psoriasis Drug Market Size Growth Rate by Application 2020-2026 (K Units) Table 8. Global Psoriasis Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 9. Global Psoriasis Drug Sales by Regions 2015-2020 (K Units) Table 10. Global Psoriasis Drug Sales Market Share by Regions (2015-2020) Table 11. Global Psoriasis Drug Revenue by Regions 2015-2020 (US$ Million) Table 12. Global Psoriasis Drug Sales Forecast by Region (2021-2026) (K Units) Table 13. Global Psoriasis Drug Sales by Manufacturers (2015-2020) (K Units) Table 14. Global Psoriasis Drug Sales Share by Manufacturers (2015-2020) Table 15. Global Psoriasis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 16. Global Psoriasis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Drug as of 2019) Table 17. Psoriasis Drug Revenue by Manufacturers (2015-2020) (US$ Million) Table 18. Psoriasis Drug Revenue Share by Manufacturers (2015-2020) Table 19. Key Manufacturers Psoriasis Drug Price (2015-2020) (USD/Unit) Table 20. Psoriasis Drug Manufacturers Manufacturing Base Distribution and Headquarters Table 21. Manufacturers Psoriasis Drug Product Type Table 22. Date of International Manufacturers Enter into Psoriasis Drug Market Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans Table 24. Global Psoriasis Drug Sales by Type (2015-2020) (K Units) Table 25. Global Psoriasis Drug Sales Share by Type (2015-2020) Table 26. Global Psoriasis Drug Revenue by Type (2015-2020) (US$ Million) Table 27. Global Psoriasis Drug Revenue Share by Type (2015-2020) Table 28. Psoriasis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 29. Global Psoriasis Drug Sales Share by Type (2021-2026) Table 30. Global Psoriasis Drug Sales by Application (2015-2020) (K Units) Table 31. Global Psoriasis Drug Sales Share by Application (2015-2020) Table 32. Global Psoriasis Drug Sales Share by Application (2021-2026) Table 33. Global Psoriasis Drug Sales Market Share Forecast by Application (2021-2026) Table 34. Global Psoriasis Drug Revenue by Application (2015-2020) (US$ Million) Table 35. Global Psoriasis Drug Revenue Market Share Forecast by Application (2021-2026) Table 36. United States Psoriasis Drug Sales (K Units) of Key Companies (2015-2020) Table 37. United States Psoriasis Drug Sales Share by Company (2015-2020) Table 38. United States Psoriasis Drug Revenue (US$ Million) by Company (2015-2020) Table 39. United States Psoriasis Drug Sales (K Units) by Type (2015-2020) Table 40. United States Psoriasis Drug Sales Share by Type (2015-2020) Table 41. United States Psoriasis Drug Revenue (US$ Million) Market Share by Type (2015-2020) Table 42. United States Psoriasis Drug Price (K Units) by Type (2015-2020) Table 43. United States Psoriasis Drug Sales (K Units) by Type (2021-2026) Table 44. United States Psoriasis Drug Sales Share by Type (2021-2026) Table 45. United States Psoriasis Drug Revenue (US$ Million) Market Share by Type (2021-2026) Table 46. United States Psoriasis Drug Revenue Share by Type (2021-2026) Table 47. United States Psoriasis Drug Price (K Units) by Type (2021-2026) Table 48. United States Psoriasis Drug Sales (K Units) by Application (2015-2020) Table 49. United States Psoriasis Drug Sales Share by Application (2015-2020) Table 50. United States Psoriasis Drug Revenue (US$ Million) Market Share by Application (2015-2020) Table 51. United States Psoriasis Drug Sales (K Units) by Application (2021-2026) Table 52. United States Psoriasis Drug Sales Share by Application (2021-2026) Table 53. United States Psoriasis Drug Revenue (US$ Million) Market Share by Application (2021-2026) Table 54. United States Psoriasis Drug Revenue Share by Application (2021-2026) Table 55. North America Psoriasis Drug Sales by Country (2015-2020) (K Units) Table 56. North America Psoriasis Drug Sales Market Share by Country (2015-2020) Table 57. North America Psoriasis Drug Revenue by Country (2015-2020) (US$ Million) Table 58. North America Psoriasis Drug Revenue Market Share by Country (2015-2020) Table 59. Europe Psoriasis Drug Sales by Country (2015-2020) (K Units) Table 60. Europe Psoriasis Drug Sales Market Share by Country (2015-2020) Table 61. Europe Psoriasis Drug Revenue by Country (2015-2020) (US$ Million) Table 62. Europe Psoriasis Drug Revenue Market Share by Country (2015-2020) Table 63. Asia Pacific Psoriasis Drug Sales by Region (2015-2020) (K Units) Table 64. Asia Pacific Psoriasis Drug Sales Market Share by Region (2015-2020) Table 65. Asia Pacific Psoriasis Drug Revenue by Region (2015-2020) (US$ Million) Table 66. Asia Pacific Psoriasis Drug Revenue Market Share by Region (2015-2020) Table 67. Latin America Psoriasis Drug Sales by Country (2015-2020) (K Units) Table 68. Latin America Psoriasis Drug Sales Market Share by Country (2015-2020) Table 69. Latin Americaa Psoriasis Drug Revenue by Country (2015-2020) (US$ Million) Table 70. Latin America Psoriasis Drug Revenue Market Share by Country (2015-2020) Table 71. Middle East and Africa Psoriasis Drug Sales by Country (2015-2020) (K Units) Table 72. Middle East and Africa Psoriasis Drug Sales Market Share by Country (2015-2020) Table 73. Middle East and Africa Psoriasis Drug Revenue by Country (2015-2020) (US$ Million) Table 74. Middle East and Africa Psoriasis Drug Revenue Market Share by Country (2015-2020) Table 75. AbbVie Corporation Information Table 76. AbbVie Description and Business Overview Table 77. AbbVie Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. AbbVie Psoriasis Drug Product Table 79. AbbVie Recent Development Table 80. Johnson & Johnson Corporation Information Table 81. Johnson & Johnson Description and Business Overview Table 82. Johnson & Johnson Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Johnson & Johnson Product Table 84. Johnson & Johnson Recent Development Table 85. Bayer Corporation Information Table 86. Bayer Description and Business Overview Table 87. Bayer Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. Bayer Product Table 89. Bayer Recent Development Table 90. Galderma Corporation Information Table 91. Galderma Description and Business Overview Table 92. Galderma Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Galderma Product Table 94. Galderma Recent Development Table 95. Bristol-Myers Squibb Corporation Information Table 96. Bristol-Myers Squibb Description and Business Overview Table 97. Bristol-Myers Squibb Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Bristol-Myers Squibb Product Table 99. Bristol-Myers Squibb Recent Development Table 100. Novartis Corporation Information Table 101. Novartis Description and Business Overview Table 102. Novartis Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. Novartis Product Table 104. Novartis Recent Development Table 105. Pfizer Corporation Information Table 106. Pfizer Description and Business Overview Table 107. Pfizer Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Pfizer Product Table 109. Pfizer Recent Development Table 110. Merz Pharma Corporation Information Table 111. Merz Pharma Description and Business Overview Table 112. Merz Pharma Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 113. Merz Pharma Product Table 114. Merz Pharma Recent Development Table 115. Valeant Corporation Information Table 116. Valeant Description and Business Overview Table 117. Valeant Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 118. Valeant Product Table 119. Valeant Recent Development Table 120. LEO Pharma Corporation Information Table 121. LEO Pharma Description and Business Overview Table 122. LEO Pharma Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. LEO Pharma Product Table 124. LEO Pharma Recent Development Table 125. GlaxoSmithKline Corporation Information Table 126. GlaxoSmithKline Description and Business Overview Table 127. GlaxoSmithKline Psoriasis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 128. GlaxoSmithKline Product Table 129. GlaxoSmithKline Recent Development Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 131. Key Challenges Table 132. Market Risks Table 133. Main Points Interviewed from Key Psoriasis Drug Players Table 134. Psoriasis Drug Customers List Table 135. Psoriasis Drug Distributors List Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Psoriasis Drug Product Picture Figure 2. Global Psoriasis Drug Sales Market Share by Type in 2020 & 2026 Figure 3. External Use Product Picture Figure 4. Oral Product Picture Figure 5. Injection Product Picture Figure 6. Global Psoriasis Drug Sales Market Share by Application in 2020 & 2026 Figure 7. Hospital Figure 8. Drugs Store Figure 9. Psoriasis Drug Report Years Considered Figure 10. Global Psoriasis Drug Market Size 2015-2026 (US$ Million) Figure 11. Global Psoriasis Drug Sales 2015-2026 (K Units) Figure 12. Global Psoriasis Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Psoriasis Drug Sales Market Share by Region (2015-2020) Figure 14. Global Psoriasis Drug Sales Market Share by Region in 2019 Figure 15. Global Psoriasis Drug Revenue Market Share by Region (2015-2020) Figure 16. Global Psoriasis Drug Revenue Market Share by Region in 2019 Figure 17. Global Psoriasis Drug Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Psoriasis Drug Revenue in 2019 Figure 19. Psoriasis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Psoriasis Drug Sales Market Share by Type (2015-2020) Figure 21. Global Psoriasis Drug Sales Market Share by Type in 2019 Figure 22. Global Psoriasis Drug Revenue Market Share by Type (2015-2020) Figure 23. Global Psoriasis Drug Revenue Market Share by Type in 2019 Figure 24. Global Psoriasis Drug Market Share by Price Range (2015-2020) Figure 25. Global Psoriasis Drug Sales Market Share by Application (2015-2020) Figure 26. Global Psoriasis Drug Sales Market Share by Application in 2019 Figure 27. Global Psoriasis Drug Revenue Market Share by Application (2015-2020) Figure 28. Global Psoriasis Drug Revenue Market Share by Application in 2019 Figure 29. United States Psoriasis Drug Sales Growth Rate 2015-2026 (K Units) Figure 30. United States Psoriasis Drug Revenue Growth Rate 2015-2026 (US$ Million) Figure 31. United States Psoriasis Drug Market Share in Global Market 2015-2026 Figure 32. United States 5 and 10 Largest Psoriasis Drug Players Market Share by Revenue in Psoriasis Drug in 2019 Figure 33. United States Psoriasis Drug Revenue Share by Type (2015-2020) Figure 34. United States Psoriasis Drug Revenue Growth Rate by Type in 2015 & 2019 Figure 35. United States Psoriasis Drug Revenue Share by Application (2015-2020) Figure 36. United States Psoriasis Drug Revenue Growth Rate by Application in 2015 & 2019 Figure 37. North America Psoriasis Drug Sales Growth Rate 2015-2020 (K Units) Figure 38. North America Psoriasis Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 39. North America Psoriasis Drug Sales Market Share by Country in 2019 Figure 40. North America Psoriasis Drug Revenue Market Share by Country in 2019 Figure 41. U.S. Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 42. U.S. Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Canada Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 44. Canada Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Europe Psoriasis Drug Sales Growth Rate 2015-2020 (K Units) Figure 46. Europe Psoriasis Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 47. Europe Psoriasis Drug Sales Market Share by Country in 2019 Figure 48. Europe Psoriasis Drug Revenue Market Share by Country in 2019 Figure 49. Germany Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 50. Germany Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. France Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 52. France Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. U.K. Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 54. U.K. Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Italy Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 56. Italy Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Russia Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 58. Russia Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Asia Pacific Psoriasis Drug Sales Growth Rate 2015-2020 (K Units) Figure 60. Asia Pacific Psoriasis Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Psoriasis Drug Sales Market Share by Region in 2019 Figure 62. Asia Pacific Psoriasis Drug Revenue Market Share by Region in 2019 Figure 63. China Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 64. China Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 66. Japan Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 68. South Korea Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 70. India Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 72. Australia Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 74. Taiwan Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 76. Indonesia Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 78. Thailand Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 80. Malaysia Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 82. Philippines Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 84. Vietnam Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Latin America Psoriasis Drug Sales Growth Rate 2015-2020 (K Units) Figure 86. Latin America Psoriasis Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America Psoriasis Drug Sales Market Share by Country in 2019 Figure 88. Latin America Psoriasis Drug Revenue Market Share by Country in 2019 Figure 89. Mexico Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 90. Mexico Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Brazil Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 92. Brazil Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Argentina Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 94. Argentina Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Middle East and Africa Psoriasis Drug Sales Growth Rate 2015-2020 (K Units) Figure 96. Middle East and Africa Psoriasis Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Psoriasis Drug Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Psoriasis Drug Revenue Market Share by Country in 2019 Figure 99. Turkey Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 100. Turkey Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 102. Saudi Arabia Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E Psoriasis Drug Sales Growth Rate (2015-2020) (K Units) Figure 104. U.A.E Psoriasis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Porter's Five Forces Analysis Figure 106. Psoriasis Drug Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Wearable Blood Glucose Monitoring Systems Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Urine Based Glucose Monitoring Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Self Glucose Monitoring Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Remote Patient Monitoring (RPM) System Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Non-wearable Blood Glucose Monitoring Systems Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Publisher: QY Research
Chat with us